Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Enochian Biosciences
Los Angeles, California, United Statesenochianbio.com ↗
- Ownership
- Public · ENOB
- Employees
- ~25
- Development stage
- Other
01
Overview
Initial clinical trials for ENOB-001 (HIV) suggest a promising safety profile, with interim data showing up to a 90% reduction in viral load in early Phase 2 evaluations. Other programs remain preclinical or at the IND-enabling stage[1][7].
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Gene therapyCell therapyMonoclonal antibodyVaccineSmall molecule
- Industry
- Biotech
02
Partnerships
The Scripps Research InstituteFred Hutchinson Cancer CenterTexas Biomedical Research InstituteUniversity of California, Los AngelesThe Hepatitis B Foundation and Baruch S. Blumberg InstituteCaring CrossXYZ Pharma
Beyond the preview
Go deeper on Enochian Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Enochian Biosciences.